Exploring host epigenetic enzymes as targeted therapies for visceral leishmaniasis: in silico design and in vitro efficacy of KDM6B and ASH1L inhibitors
Article in Molecular Diversity (March 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in Molecular Diversity (March 2024)
Conference proceeding in Medical Sciences Forum (April 2023)
Article in Expert Opinion on Therapeutic Patents (March 2023)